NASDAQ:KALA
Kala Pharmaceuticals, Inc.
- Stock
locale
United States
market
STOCKSindustry
Drug Manufacturers - Specialty & Genericwebsite
www.kalarx.comipo date
Jul 20, 2017
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent corneal epithelial defects; EYSU...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus